Japan approves Digene's chlamydia and gonorrhea DNA test:
This article was originally published in Clinica
Executive Summary
Digene has gained Japanese go-ahead to market its DNA test for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) in cervical specimens. The Hybrid Capture 2 CT/GC test will be distributed in Japan by Chiyoda-Ku, Tokyo based Mitsubishi Kagaku Medical, a subsidiary of Mitsubishi Chemical.